Canurta.ethThe Satoshi Trials™: A Bitcoin Treasury Reserve Thesis
Date of Original Draft: Dec 15, 2024. Special Note: The initial Bitcoin price considered for these calculations is $100,000 USD per BTC given we [had on Dec 15th, 2024] passed the psychological price benchmark. Setting the Stage for Disruption Biotechnology has long grappled with the high costs and uncertainty of drug development, leaving promising therapies for diseases like ALS underfunded. At Canurta, we recognize the need for a transformative approach—one that not only addresses these cha...
Canurta.ethThe Canurta White Paper: Grounds for Further Investigation into Hemp Polyphenols
Written by Akeem Gardner, LLB Originally published on September 28, 2021 in Canurta’s Journal A quick note from Akeem before we begin: “2021 was an amazing year. From the launch of our company we grew by acquiring additional IP and investors who are supporting our mission to heal the world with novel polyphenols that have never been clinically explored before. Our team has shown so much growth in our journey of discovery and learning, and it’s now time to implement our DeSci strategy for our ...
Canurta.ethBuilt to Last, Not to Flex
A Founder's Note — Akeem Gardner"Thus, the deluded Bankrupt raves; Puts all upon a desprate Bet; Then plunges in the Southern Waves; Dipt over Head and Ears—in Debt."Life has a unique way of guiding us exactly where we need to be, often without us fully realizing it at the time. My journey led me to study law at the University of Kent, Canterbury, a path seemingly unrelated to my core passion—innovation and entrepreneurship. Yet, it was precisely in my Company Law class in October 2015 w...
an emerging biotech company using rare hemp polyphenols and DeSci to create safe and effective natural therapeutics
Canurta.ethThe Satoshi Trials™: A Bitcoin Treasury Reserve Thesis
Date of Original Draft: Dec 15, 2024. Special Note: The initial Bitcoin price considered for these calculations is $100,000 USD per BTC given we [had on Dec 15th, 2024] passed the psychological price benchmark. Setting the Stage for Disruption Biotechnology has long grappled with the high costs and uncertainty of drug development, leaving promising therapies for diseases like ALS underfunded. At Canurta, we recognize the need for a transformative approach—one that not only addresses these cha...
Canurta.ethThe Canurta White Paper: Grounds for Further Investigation into Hemp Polyphenols
Written by Akeem Gardner, LLB Originally published on September 28, 2021 in Canurta’s Journal A quick note from Akeem before we begin: “2021 was an amazing year. From the launch of our company we grew by acquiring additional IP and investors who are supporting our mission to heal the world with novel polyphenols that have never been clinically explored before. Our team has shown so much growth in our journey of discovery and learning, and it’s now time to implement our DeSci strategy for our ...
Canurta.ethBuilt to Last, Not to Flex
A Founder's Note — Akeem Gardner"Thus, the deluded Bankrupt raves; Puts all upon a desprate Bet; Then plunges in the Southern Waves; Dipt over Head and Ears—in Debt."Life has a unique way of guiding us exactly where we need to be, often without us fully realizing it at the time. My journey led me to study law at the University of Kent, Canterbury, a path seemingly unrelated to my core passion—innovation and entrepreneurship. Yet, it was precisely in my Company Law class in October 2015 w...
an emerging biotech company using rare hemp polyphenols and DeSci to create safe and effective natural therapeutics
Subscribe to Canurta.eth
Subscribe to Canurta.eth
Share Dialog
Share Dialog
<100 subscribers
<100 subscribers
— A Founder’s Note
When I first began building Canurta, it was with the belief that nature holds solutions to some of our most complex human conditions — including neurodegenerative diseases like ALS. What I didn’t expect was how much I would come to see Bitcoin not just as digital money, but as a form of digital energy — and perhaps, even more importantly, as a protocol for resilience.
Today, I’m proud to share that we’ve set up and are running a full Bitcoin node at Canurta.
This might seem like a strange move for a biotechnology company. But for me, it’s a natural progression of what we believe in: decentralization, integrity, and energy that cannot be corrupted. Bitcoin isn’t just a network. It’s an architecture. And increasingly, I think it’s an architecture that science and medicine need.
We are working every day to build the Polykye Platform — our infrastructure for adaptive, botanical therapeutics. As we begin rolling out our Satoshi Trials program for ALS research, I want to be able to say that the work we do is grounded in more than theory — it’s anchored to something verifiable, distributed, and open.
Running a Bitcoin node is part of that commitment.
It allows us to:
Independently verify and interact with the Bitcoin network
Begin exploring tools like timestamping, decentralized registries, and protocol-native research documentation
Bring the same integrity and transparency we demand in science into the systems that support it
For those who’ve followed Canurta’s journey, you already know we’re obsessed with the intersection of plant intelligence, human resilience, and decentralized systems. This is one of the first visible steps in a longer roadmap to bring blockchain technologies into the heart of scientific research — not for hype, but for coordination, accountability, and freedom.
This isn’t just about Bitcoin.
It’s about refusing to build tomorrow’s therapies on yesterday’s infrastructure.
More to come soon — on how we see Bitcoin’s architecture shaping the next generation of adaptive therapeutics, and why we believe this matters for people living with ALS.
For now, just know this:
The chain is syncing.
And the mission continues.
— Akeem
Founder & CEO, Canurta Therapeutics
"Want to Learn More?":
If you're curious about why running your own Bitcoin node matters—for decentralization, resilience, and security—these resources provide a great starting point:
— A Founder’s Note
When I first began building Canurta, it was with the belief that nature holds solutions to some of our most complex human conditions — including neurodegenerative diseases like ALS. What I didn’t expect was how much I would come to see Bitcoin not just as digital money, but as a form of digital energy — and perhaps, even more importantly, as a protocol for resilience.
Today, I’m proud to share that we’ve set up and are running a full Bitcoin node at Canurta.
This might seem like a strange move for a biotechnology company. But for me, it’s a natural progression of what we believe in: decentralization, integrity, and energy that cannot be corrupted. Bitcoin isn’t just a network. It’s an architecture. And increasingly, I think it’s an architecture that science and medicine need.
We are working every day to build the Polykye Platform — our infrastructure for adaptive, botanical therapeutics. As we begin rolling out our Satoshi Trials program for ALS research, I want to be able to say that the work we do is grounded in more than theory — it’s anchored to something verifiable, distributed, and open.
Running a Bitcoin node is part of that commitment.
It allows us to:
Independently verify and interact with the Bitcoin network
Begin exploring tools like timestamping, decentralized registries, and protocol-native research documentation
Bring the same integrity and transparency we demand in science into the systems that support it
For those who’ve followed Canurta’s journey, you already know we’re obsessed with the intersection of plant intelligence, human resilience, and decentralized systems. This is one of the first visible steps in a longer roadmap to bring blockchain technologies into the heart of scientific research — not for hype, but for coordination, accountability, and freedom.
This isn’t just about Bitcoin.
It’s about refusing to build tomorrow’s therapies on yesterday’s infrastructure.
More to come soon — on how we see Bitcoin’s architecture shaping the next generation of adaptive therapeutics, and why we believe this matters for people living with ALS.
For now, just know this:
The chain is syncing.
And the mission continues.
— Akeem
Founder & CEO, Canurta Therapeutics
"Want to Learn More?":
If you're curious about why running your own Bitcoin node matters—for decentralization, resilience, and security—these resources provide a great starting point:
No activity yet